rivipansel: Clinical Trials

6 completed. 6 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	6	Completed 6
Phase 2	1	Completed 1

Follow rivipansel: new trials by email Literature Review of rivipansel trials Research Report on rivipansel

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel. Rivipansel - Healthy	Phase 1	Completed	GlycoMimetics Incorporated	16	2017-01-01	2020-06-18
A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function Rivipansel - Moderate Hepatic Impairment, Normal Hepatic Function	Phase 1	Completed	GlycoMimetics Incorporated	16	2016-09-01	2020-07-09
A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects Rivipansel - Renal Impairment, Healthy	Phase 1	Completed	GlycoMimetics Incorporated	28	2016-06-01	2020-06-18
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Rivipansel With rHuPH20 in Healthy Subjects Rivipansel, Placebo - Healthy	Phase 1	Completed	GlycoMimetics Incorporated	27	2015-10-01	2020-06-18
A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subjects Rivipansel - Healthy	Phase 1	Completed	GlycoMimetics Incorporated	48	2013-08-01	2020-06-18
Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease GMI-1070 - Sickle Cell Disease	Phase 1 / Phase 2	Completed	GlycoMimetics Incorporated	15	2009-05-01	2020-05-11

Conditions studied

Anemia, Sickle Cell (1)  ·  Renal Insufficiency (1)

Sponsors

GlycoMimetics Incorporated (6)

Countries

United States (5)  ·  Belgium (1)

Top investigators

Helen Thackray, MD (1)

Results publications

PMID 32579796, PMID 24988449

NIH funding

2014 (1)